Indication
Enterococcal endocarditis
Enterococcal endocarditis is a severe, life-threatening infection of the cardiac endocardium and heart valves caused by bacteria of the genus *Enterococcus*, most frequently *Enterococcus faecalis*. Read more about Enterococcal endocarditis
78 drugs 45 manufacturers
Drugs that treat it
Common Enterococcal endocarditis therapies.
VANCOMYCIN HCL
VANCOMYCIN HCL
VANCOMYCIN HCL
VANCOMYCIN HCL-D5W (vancomycin in 5 % dextrose in water)
VANCOMYCIN HCL
AMPICILLIN SODIUM
VANCOMYCIN HCL
AMPICILLIN SODIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEnterococcal endocarditis is a severe, life-threatening infection of the cardiac endocardium and heart valves caused by bacteria of the genus *Enterococcus*, most frequently *Enterococcus faecalis*.
Primarily affecting older adults and individuals with prosthetic valves, structural heart disease, or healthcare-associated bacteremia originating from genitourinary or gastrointestinal sources, the condition typically presents as a subacute systemic illness.
Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization.
- nih.gov
Enterococcal endocarditis is a severe, life-threatening infection of the cardiac endocardium and heart valves caused by bacteria of the genus *Enterococcus*, most frequently *Enterococcus faecalis* Primarily affecting older adults and individuals with prosthetic valves, structural heart disease, or healthcare-associated bacteremia originating from genitourinary or gastrointestinal sources, the condition typically presents as a subacute systemic illness
- clinicaltrials.eu
Enterococcal endocarditis is a severe, life-threatening infection of the cardiac endocardium and heart valves caused by bacteria of the genus *Enterococcus*, most frequently *Enterococcus faecalis* Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization
- nih.gov
Primarily affecting older adults and individuals with prosthetic valves, structural heart disease, or healthcare-associated bacteremia originating from genitourinary or gastrointestinal sources, the condition typically presents as a subacute systemic illness
- nih.gov
Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization
- nih.gov
Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization
- idsociety.org
Pathophysiologically, enterococci adhere to native or artificial endocardial surfaces to generate biofilm-encased fibrin and platelet vegetations, which can lead to progressive valvular destruction, heart failure, and systemic embolization
Personalize your experience
Follow Enterococcal endocarditis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.